Increased Intestinal Inflammation and Permeability in Glaucoma
Zuo Wang,Siqi Guo,Chong He,Lingling Chen,Jinxia Wang,Wenbo Xiu,Gao Zhang,Yang Chen,An Li,Xiong Zhu,Xiao Xiao,Ling Yu,Fang Lu
DOI: https://doi.org/10.2147/jir.s480809
IF: 4.5
2024-10-01
Journal of Inflammation Research
Abstract:Zuo Wang, 1, 2, &ast Siqi Guo, 3, &ast Chong He, 2, 4, &ast Lingling Chen, 5 Jinxia Wang, 2 Wenbo Xiu, 2 Gao Zhang, 2 Yang Chen, 2 An Li, 2 Xiong Zhu, 6 Xiao Xiao, 2 Ling Yu, 3 Fang Lu 2, 4, 7 1 Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Republic of China; 2 Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China; 3 Department of Ophthalmology, Daping Hospital, Army Medical Center, Army Medical University, Chongqing, People's Republic of China; 4 Medico-Engineering Cooperation on Applied Medicine Research Center, University of Electronic Science and Technology of China, Chengdu, People's Republic of China; 5 Department of Immunology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, People's Republic of China; 6 Department of Prenatal Diagnosis, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China; 7 Health Management Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ling Yu; Fang Lu, Email ; Objective: Evidence suggests that dysbiosis of the gut microbiota plays a pivotal role in the development of glaucoma. This dysbiosis is commonly associated with chronic intestinal inflammation and increased intestinal permeability. However, the understanding of intestinal inflammation and permeability in glaucoma remains insufficient. This study aims to investigate the potential relationship between fecal inflammation and permeability markers and glaucoma. Methods: We recruited 114 glaucoma patients and 75 healthy controls. Levels of fecal lactoferrin (Lf) and alpha-1 antitrypsin (AAT) were quantified using enzyme linked immunosorbent assay (ELISA) to compare both biomarkers between groups and across different severity grades of glaucoma. Logistic regression analysis was used to assess the association between these fecal biomarkers and glaucoma. The severity of glaucoma was assessed based on the mean deviation (MD) in the visual field. Results: In this study, we observed elevated levels of fecal Lf and AAT in glaucoma patients. The proportion of glaucoma patients with abnormal fecal Lf levels (≥ 7.25 μg/g) was significantly higher than that of the controls ( p = 0.012). A positive correlation was noted between fecal Lf and AAT (rho = 0.20, p = 0.006). After adjusting for age and sex, multivariable logistic regression analysis indicated that both fecal Lf (OR = 1.11, 95% CI: 1.01– 1.21, p = 0.026) and AAT (OR = 1.01, 95% CI: 1.01– 1.02, p < 0.001) positively correlated with glaucoma. These biomarkers might reflect glaucoma severity, with significant differences in fecal Lf levels observed between moderate and severe stages, but not in the early stage. Furthermore, increasing levels of fecal AAT correlated with greater severity of glaucomatous injury and a larger vertical cup-to-disc ratio (VCDR) ( p < 0.05). Conclusion: This study suggests an increase in intestinal inflammation and permeability in glaucoma, further indicating the importance of the 'gut-retina axis' in the pathogenesis of the disease and potentially offering new therapeutic avenues. Keywords: fecal lactoferrin, fecal alpha-1 antitrypsin, glaucoma, intestinal inflammation, intestinal permeability, intestinal barrier Glaucoma, the second leading cause of blindness worldwide, currently affects approximately 80 million people globally. 1 This complex neurodegenerative condition is primarily characterized by the degeneration of the optic nerve, reduction of retinal ganglion cells (RGCs), and visual field defects. 1,2 Although elevated intraocular pressure (IOP) is traditionally viewed as a principal contributor to glaucomatous damage, some patients exhibit normal IOP levels. 2 Recent studies have suggested that alterations of the gut environment may be implicated in glaucoma. 3–5 Specifically, some research has demonstrated alterat -Abstract Truncated-
immunology